Skip to main content
TipRanks
Go Ultimate75% OFF

Annexin Pharmaceuticals AB (ANNX) Cash flow

2 Followers

Annexin Pharmaceuticals AB Cash Flow

SE:ANNX's free cash flow for Q3 2026 was kr-9.95M. For the 2026 fiscal year, SE:ANNX's free cash flow was increased by kr0.00 and operating cash flow was kr-9.95M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
kr -36.92Mkr -50.23Mkr -43.40Mkr -41.16Mkr -45.02M
kr -129.00Kkr 0.00kr 96.00Kkr -260.00Kkr 0.00
kr 48.11Mkr 45.15Mkr 33.61Mkr 23.06Mkr 76.37M
kr 27.39Mkr 16.34Mkr 21.41Mkr 31.11Mkr 49.48M
kr -37.05Mkr -50.23Mkr -43.40Mkr -41.16Mkr -45.02M

Currency in SEK

Annexin Pharmaceuticals AB Cash Flow

-75M-50M-25M025M50M75M100M201720182019202020212022202320242025OperatingInvestingFinancing